347 related articles for article (PubMed ID: 16964386)
1. OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.
Tammela J; Uenaka A; Ono T; Noguchi Y; Jungbluth AA; Mhawech-Fauceglia P; Qian F; Schneider S; Sharma S; Driscoll D; Lele S; Old LJ; Nakayama E; Odunsi K
Int J Oncol; 2006 Oct; 29(4):903-10. PubMed ID: 16964386
[TBL] [Abstract][Full Text] [Related]
2. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ
Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938
[TBL] [Abstract][Full Text] [Related]
3. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
4. SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.
Tammela J; Jungbluth AA; Qian F; Santiago D; Scanlan MJ; Keitz B; Driscoll D; Rodabaugh K; Lele S; Old LJ; Odunsi K
Cancer Immun; 2004 Oct; 4():10. PubMed ID: 15487888
[TBL] [Abstract][Full Text] [Related]
5. A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.
Sharma S; Qian F; Keitz B; Driscoll D; Scanlan MJ; Skipper J; Rodabaugh K; Lele S; Old LJ; Odunsi K
Gynecol Oncol; 2005 Oct; 99(1):183-8. PubMed ID: 16005946
[TBL] [Abstract][Full Text] [Related]
6. Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells.
Valmori D; Qian F; Ayyoub M; Renner C; Merlo A; Gnjatic S; Stockert E; Driscoll D; Lele S; Old LJ; Odunsi K
Clin Cancer Res; 2006 Jan; 12(2):398-404. PubMed ID: 16428478
[TBL] [Abstract][Full Text] [Related]
7. Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.
Hylander B; Repasky E; Shrikant P; Intengan M; Beck A; Driscoll D; Singhal P; Lele S; Odunsi K
Gynecol Oncol; 2006 Apr; 101(1):12-7. PubMed ID: 16263157
[TBL] [Abstract][Full Text] [Related]
8. Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.
Luo B; Yun X; Fan R; Lin YD; He SJ; Zhang QM; Mo FR; Chen F; Xiao SW; Xie XX
Int J Clin Exp Pathol; 2013; 6(12):2835-45. PubMed ID: 24294369
[TBL] [Abstract][Full Text] [Related]
9. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.
Ono T; Kurashige T; Harada N; Noguchi Y; Saika T; Niikawa N; Aoe M; Nakamura S; Higashi T; Hiraki A; Wada H; Kumon H; Old LJ; Nakayama E
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3282-7. PubMed ID: 11248070
[TBL] [Abstract][Full Text] [Related]
10. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance.
Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y
Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732
[TBL] [Abstract][Full Text] [Related]
11. Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.
Luo B; Yun X; Li J; Fan R; Guo WW; Liu C; Lin YD; Ge YY; Zeng X; Bi SQ; Nong WX; Zhang QM; Xie XX
Curr Med Sci; 2020 Aug; 40(4):719-728. PubMed ID: 32862383
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of mammaglobin B in epithelial ovarian carcinomas.
Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD
Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903
[TBL] [Abstract][Full Text] [Related]
13. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
[TBL] [Abstract][Full Text] [Related]
14. Cancer testis antigen OY-TES-1: analysis of protein expression in ovarian cancer with tissue microarrays.
Fan R; Huang W; Luo B; Zhang QM; Xiao SW; Xie XX
Eur J Gynaecol Oncol; 2015; 36(3):298-303. PubMed ID: 26189257
[TBL] [Abstract][Full Text] [Related]
15. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
[TBL] [Abstract][Full Text] [Related]
16. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
Wang L; Madigan MC; Chen H; Liu F; Patterson KI; Beretov J; O'Brien PM; Li Y
Gynecol Oncol; 2009 Aug; 114(2):265-72. PubMed ID: 19450871
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of OY-TES-1 by RNAi causes cell cycle arrest and migration decrease in bone marrow-derived mesenchymal stem cells.
Cen YH; Guo WW; Luo B; Lin YD; Zhang QM; Zhou SF; Luo GR; Xiao SW; Xie XX
Cell Biol Int; 2012 Oct; 36(10):917-22. PubMed ID: 22651134
[TBL] [Abstract][Full Text] [Related]
18. Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma.
Li X; Yan J; Fan R; Luo B; Zhang Q; Lin Y; Zhou S; Luo G; Xie X; Xiao S
Oncol Lett; 2017 May; 13(5):3080-3086. PubMed ID: 28529561
[TBL] [Abstract][Full Text] [Related]
19. CABYR is a novel cancer-testis antigen in lung cancer.
Luo C; Xiao X; Liu D; Chen S; Li M; Xu A; Liu J; Gao S; Wu S; He D
Clin Cancer Res; 2007 Feb; 13(4):1288-97. PubMed ID: 17317841
[TBL] [Abstract][Full Text] [Related]
20. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
Wang P; Wu X; Chen W; Liu J; Wang X
Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
